Fresenius Med Care: stock up on analyst comments

(CercleFinance.com) - Going against the grain in Frankfurt, with the DAX down 0.
4% at Friday lunchtime, the Fresenius Medical Care share is currently up 0.8%, following Credit Suisse comments, which although maintaining its "neutral" rating on the share of the dialysis specialist, has raised its corresponding target price from 81 euros to 84 euros.

"While pandemic developments are difficult to predict and with FMC caring for vulnerable patients, we are encouraged to see material government support, which makes us share management confidence that the effects can be absorbed within the original guidance," the analyst said.



Copyright (c) 2020 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.